Quick Answer
Trulieve Cannabis Corp. reported Cash and Equivalents of $255.53 million for fiscal year 2025.
Trulieve Cannabis Corp. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $255.53M | +7.0% |
| 2024 | $238.80M | +18.6% |
| 2023 | $201.37M | -2.8% |
| 2022 | $207.19M | -8.6% |
| 2021 | $226.63M | +54.5% |
| 2020 | $146.71M | +59.8% |
| 2019 | $91.81M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $449.20M | +89.0% | +14.4% |
| June 30, 2025 | $392.58M | +10.5% | +19.5% |
| March 31, 2025 | $328.45M | +2.5% | +37.5% |
| December 31, 2024 | $238.80M | +18.6% | +0.5% |
| September 30, 2024 | $237.67M | +23.7% | -33.1% |
| June 30, 2024 | $355.18M | +133.1% | +10.9% |
| March 31, 2024 | $320.31M | +72.5% | +59.1% |
| December 31, 2023 | $201.37M | -2.8% | +4.8% |
- Trulieve Cannabis Corp. showed an increase of +7.0% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2019–2025 period, Trulieve Cannabis Corp.’s cash and equivalents has grown by 178.3% (from $91.81 million to $255.53 million).
- The most recent figure is from Trulieve Cannabis Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: